Sinofn Health
Sinofn Health
In an era where health consumerism is shifting toward hyper-personalization, SINOFN Health stands as a beacon of science-driven manufacturing. The nutraceutical industry is currently grappling with supply chain fragmentation and the rising demand for "clean label" transparency. As a premier ODM/OEM partner, SINOFN bridges the gap between high-level laboratory research—backed by the Chinese Academy of Sciences—and commercial scalability.
Our macro-industry solution isn't just about manufacturing; it's about *formulation engineering*. We analyze consumer biological trends and regulatory shifts across key markets (US, EU, APAC) to ensure that every product leaving our facility is not only effective but fully compliant with regional market access standards.
Expertise is not a buzzword at SINOFN; it is our foundation. Led by Dr. Tan Shengjie (Peking University Medical School) and Dr. Zhang Ying (CAS Postdoc), our R&D department treats supplements with the rigor of pharmaceutical development.
Unlike generic manufacturers, we focus on bioavailability. Whether it's NMN purity, protein admixture stability, or collagen peptide absorption, our "Formulation Director" Hans van Dijk ensures EU-standard compliance in every prototype.
We provide full documentation, from GMP certification to stability testing, enabling global brands to launch with confidence in highly regulated markets like the EU and FDA jurisdictions.
Global brands often struggle with localizing products for specific cultural and biological demographics. SINOFN provides bespoke solutions for:
Looking ahead, SINOFN is integrating Artificial Intelligence into our R&D roadmap. We are exploring AI-driven ingredient blending to predict consumer needs before they hit the mass market. By analyzing real-time data on health trends, we are transitioning from a traditional manufacturer to a "Solution Provider," where the supply chain becomes an intelligent, reactive network.
A: We utilize a "Pilot-to-Scale" methodology. Our R&D center, connected to the Chinese Academy of Sciences, develops the complex formulation. We then run small-batch pilot trials in our GMP-certified facility to validate stability before moving to full-scale automated production.
A: Yes. With specialists like Hans van Dijk, we ensure that labeling, ingredient safety, and documentation meet the specific nuances of target regions, including FDA/EFSA/TGA compliance benchmarks.
